TREM-1 regulates macrophage polarization in ureteral obstruction

Kidney International

Volumn 86, Issue 6, 2014, Pages 1174-1186

  Lo, Tzu Han ^a   Tseng, Kai Yu ^a   Tsao, Wen Shan ^a   Yang, Chih Ya ^a,b   Hsieh, Shie Liang ^a,b,c,d   Chiu, Allen Wen Hsiang ^a   Takai, Toshiyuki ^e   Mak, Tak W ^f   Tarng, Der Cherng ^a,c   Chen, Nien Jung ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TOHOKU UNIVERSITY   (Japan)

^f PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Chronic kidney disease; Fibrosis; Immunology and pathology; Macrophages; Obstructive nephropathy

Indexed keywords

COLLAGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; MESSENGER RNA; TREM1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL LYSATE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY DISEASE; KIDNEY TUBULE DAMAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NEPHRITIS; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; UPREGULATION; URETER OBSTRUCTION; ADULT; AGED; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL POLARITY; COMPLICATION; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL DIFFERENTIATION; CELL POLARITY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MIDDLE AGED; NEPHRITIS; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; UP-REGULATION; URETERAL OBSTRUCTION;

EID: 84926142468     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.205     Document Type: Article

References (37)

1. Lopez-Novoa JM, Martinez-Salgado C, Rodriguez-Pena AB et al. Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives. Pharmacol Ther 2010; 128: 61-81.
2. Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest 2008; 118: 3522-3530.
3. Schiffer L, Bethunaickan R, Ramanujam M et al. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol 2008; 180: 1938-1947.
4. Vielhauer V, Kulkarni O, Reichel CA et al. Targeting the recruitment of monocytes and macrophages in renal disease. Semin Nephrol 2010; 30: 318-333.
5. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 2002; 283: F861-F875.
6. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol 2008; 181: 3733-3739.
7. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15: 323-350.
8. Chang NC, Hung SI, Hwa KY et al. A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin. J Biol Chem 2001; 276: 17497-17506.
9. Raes G, Noel W, Beschin A et al. FIZZ1 and Ym as tools to discriminate between differentially activated macrophages. Dev Immunol 2002; 9: 151-159.
10. Stein M, Keshav S, Harris N et al. Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation. J Exp Med 1992; 176: 287-292.
11. Dumont P, Berton A, Nagy N et al. Expression of galectin-3 in the tumor immune response in colon cancer. Lab Invest 2008; 88: 896-906.
12. Tsunawaki S, Sporn M, Ding A et al. Deactivation of macrophages by transforming growth factor-beta. Nature 1988; 334: 260-262.
13. Savill J, Dransfield I, Gregory C et al. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002; 2: 965-975.
14. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
15. Bouchon A, Facchetti F, Weigand MA et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410: 1103-1107.
16. Klesney-Tait J, Turnbull IR, Colonna M. The TREM receptor family and signal integration. Nat Immunol 2006; 7: 1266-1273.
17. McVicar DW, Taylor LS, Gosselin P et al. DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk proteintyrosine kinase. J Biol Chem 1998; 273: 32934-32942.
18. Lanier LL. DAP10-and DAP12-associated receptors in innate immunity. Immunol Rev 2009; 227: 150-160.
19. Gibot S, Cravoisy A, Levy B et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004; 350: 451-458.
20. Lin YT, Tseng KY, Yeh YC et al. TREM-1 promotes survival during Klebsiella pneumoniae liver abscess in mice. Infect immun 2014; 82: 1335-1342.
21. Kuai J, Gregory B, Hill A et al. TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines. Rheumatology (Oxford) 2009; 48: 1352-1358.
22. Schenk M, Bouchon A, Seibold F et al. TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J Clin Invest 2007; 117: 3097-3106.
23. Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009; 75: 1145-1152.
24. Klesney-Tait J, Keck K, Li X et al. Transepithelial migration of neutrophils into the lung requires TREM-1. J Clin Invest 2013; 123: 138-149.
25. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008; 8: 533-544.
26. Verreck FA, de Boer T, Langenberg DM et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 2004; 101: 4560-4565.
27. Fleetwood AJ, Lawrence T, Hamilton JA et al. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol 2007; 178: 5245-5252.
28. Wu MF, Chen ST, Yang AH et al. CLEC5A is critical for dengue virusinduced inflammasome activation in human macrophages. Blood 2013; 121: 95-106.
29. Wu J, Li J, Salcedo R et al. The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. Cancer Res 2012; 72: 3977-3986.
30. Kaifu T, Nakahara J, Inui M et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest 2003; 111: 323-332.
31. Wang Y, Cao Q, Zheng G et al. By homing to the kidney, activated macrophages potently exacerbate renal injury. Am J Pathol 2008; 172: 1491-1499.
32. Cao Q, Wang Y, Zheng D et al. Failed renoprotection by alternatively activated bone marrow macrophages is due to a proliferation-dependent phenotype switch in vivo. Kidney Int 2014; 85: 794-806.
33. Tammaro A, Stroo I, Rampanelli E et al. Role of TREM1-DAP12 in renal inflammation during obstructive nephropathy. PLoS One 2013; 8: e82498.
34. te Witt R, van Wolfswinkel ME, Petit PL et al. Neopterin and procalcitonin are suitable biomarkers for exclusion of severe Plasmodium falciparum disease at the initial clinical assessment of travellers with imported malaria. Malar J 2010; 9: 255.
35. Sharif O, Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 2008; 213: 701-713.
36. Gibot S, Buonsanti C, Massin F et al. Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infect Immun 2006; 74: 2823-2830.
37. Haselmayer P, Grosse-Hovest L, von Landenberg P et al. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 2007; 110: 1029-1035.